Jan-Christopher Kamp

31PUBLICATIONS

108CO-AUTHORS

Molecular targetsFoetal development and medicineClinical neuropsychologyTissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (31)

Sort by Publication Date:

|Jul 09, 2026

Aberrant and Ectopic Cell Populations in Restrictive Allograft Syndrome after Lung Transplantation.

|Jun 12, 2026

Peripartum-Associated Heart Failure Develops Independently of RHOT Proteins.

|Jun 08, 2026

Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With Sotatercept.

|May 08, 2026

The pleuroparenchymal fibroelastosis atlas reveals aberrant cell states and their zonation as an alternate roadmap to lung fibrosis.

|Apr 01, 2026

Initial triple combination therapy including sotatercept in a patient with severe idiopathic pulmonary arterial hypertension: a case report.

Da-Hee Park, Jan-Christopher Kamp, Benjamin Seeliger

|Mar 06, 2026

Optimized culture of primary human alveolar type II cell-derived 3D organoids from fibrotic lung tissue with phenotypic and metabolic profiling.

Lara-Jasmin Schröder, Julia Rückoldt, Stephanie Schubert

Pageof 6

Frequent Collaborators

14 joint publications

Marius M Hoeper

12 joint publications

Jan Fuge

Jonas C Schupp

Christopher Werlein

Maximilian Ackermann

Danny Jonigk

Da-Hee Park

Jens Gottlieb

Lars Knudsen

Naftali Kaminski

Frequent Collaborators

14 joint publications

Marius M Hoeper

12 joint publications

Jan Fuge

5 joint publications

Jonas C Schupp

5 joint publications

Christopher Werlein